ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Photodynamic Therapy for Malignant Airway Disease

Fayez Kheir

Perioperative vs. Preoperative Surgery in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

Respiratory Tract, EBUS, Molecular Biomarker Testing in Non-Small Ce…

Houston Methodist

S. Roy-Chowdhuri

Management of mNSCLC Without Actionable Mutations

Integrity CE

M. Baumgart, S. Liu

The Changing Prognosis of Lung Cancer Brain Metastases

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

S. Goldberg

Diagnosis and Staging of Lung Cancer in the Era of Advanced Diagnost…

Cleveland Clinic Respiratory Institute

F. Almeida

Lung Resection in Early Stage NSCLC: An Overview

GRACE

C. Jeffrey Yang

Management of Stage IV NSCLC With Actionable Mutations

Integrity CE

G. Dy

Neoadjuvant Chemoimmunotherapy in Unresectable NSCLC

MI&T Congressi

I. Opitz

mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC

OncoAlert

C. Aggarwal

Current Recommendations on Managing Dermatologic Adverse Reactions A…

Fawzi Abu Rous

2024 Neuro-Oncology Update: NSCLC and Brain Mets

Scripps Health

T. McGranahan

Changing Systemic Therapy Post Oligoprogression in the CNS

MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

G. Riely